Cardiologia - i registri TAVI

TAVI: registri

Trial randomizzati (PARTNER)

Valvole percutanee

TAVI: sopravvivenza

TAVI: effetto su mortalità

Efficacia TAVI su classe NYHA

Efficacia TAVI su classe NYHA

Valvole percutanee: protesi su protesi

Eur Heart J 2011;32:140–147

J Am Coll Cardiol 2010;55:97–101

Circulation 2010;121:1848–1857

Complicanze: stroke

Main outcomes in mortality and stroke in the PARTNER trial after 30 days and 1 year of follow-up.

• A: Cohort A, patients at high surgical risk who underwent percutaneous transcatheter aortic valve implantation versus aortic valve replacement surgery.
• B: Cohort A, candidates for percutaneous transcatheter aortic valve implantation via the transfemoral approach versus aortic valve replacement surgery.
• C: Cohort A, patients in whom percutaneous transthoracic aortic valve implantation via transfemoral access was not possible, who were treated using the transapical approach, versus aortic valve replacement surgery.
• D: Cohort B, inoperable patients who underwent percutaneous transcatheter aortic valve implantation versus medical treatment.

AVR, aortic valve replacement; TAVI, percutaneous transcatheter aortic valve implantation.

Complicanze

EuroIntervention 2010;5:659–665

Complicanze coronariche

.KaSulefpeCa97WetraCa

Gestione stenosi aortica